8
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Monthly Update: Anti-Infectives the Immunomodulatory Activities of Antibacterials

Pages 551-557 | Published online: 03 Mar 2008

References

  • SALYERS AA, winil DD: Bacterial Pathogenesis. ASM Press, Washington, DC (1994).
  • BOLLA K, CAPPEL R, DUCHATEAU J: Activation of periph- eral blood lymphocytes as a potential basic mechanism of immunomodulation. Int. J. Immunother. (1987) 1E171-79. Good research effort in the description of the biology of immuno-modulation of lymphocytes.
  • LABRO MT: Imtnunomodulation by antibacterial agents. Is it clinically relevant? Drugs (1993) 45:319–328.
  • GEMMELL CG: Antibiotics and neutrophil function - potential immunomodulatory activities. J. Antimicrob. Chemotber. (1993) 31(S u ppl B):23–33.
  • STUNKEL KGE, HEWLETT G, ZEILER IV: Ciprofloxacin ••enhances T-cell function by modulating interleukinactivities. Chn. Exp. Immunol. (1991) 86:525-531. Good description of the effect of the 4-quinolone, ciprofloxacin, on interleukin biological activities.
  • DELFINO D, BONINA L, BERLINGFIIERI MC, MASTROENI P: Effects of a new quinolone derivative, ciprofloxacin, on some professional phagocytotic cell function. Cbemioterapia (1985) 4:463–466.
  • RIESBECK K, FORSGREN A: Selective enhancement ofsynthesis of interleukin-2 in lymphocytes in the pres-ence of ciprofloxacin. Eur. J. din. Microbiol. Infect. Dis. (1990) 9:409–413.
  • ZEHAVI-WILLNER T, SHALIT I: Enhancement of inter-leukin-2 production Inhuman lymphocytes by two new quinolone derivatives. Lympbokine Res. (1989) 8:35–46.
  • ROCIIE Y, FAY M, GOUGEROT-POCIDALO M-A: Enhance-ment of interleultin-2 production by quinolone-treated human mononuclear leukocytes. Int. J. Immunophar-mac. (1988) 10:161–167.
  • RIESBECK K, ANDERSON J, GULLBERG M, FORSGREN A:fluorinated 4-quinolones induce hyperproduction of interleukin-2. Proc. Natl. Acad. Sci. USA (1989) 86:2809–2813.
  • BAILLY S, MAHE Y, FERRUA B, FAY M, TURSZ T, WAKASUGIH, GOUGEROT-POCIDALO M-A. Quinolone-induced dif-ferential modification of IL-la and IL-1l production by LPS-stimulated human monocytes. Cellular Immunology (1990) 128:277–288.
  • ROCHE Y, FAY M, GOUGEROT-POCIDALO M: Effects of quinolones on interleukin-1 production in vitro by human monocytes. Immunopharmacology (1987) 13:99–109.
  • FORSGREN A, BREDBERG A, PARDEE AB, SCHLOSSMAN esSF, TEDDER TF: Effects of ciprofloxacin on eucaryotic pyrimidine nucleotide biosynthesis and cell growth. Antimicrob. Agents Chemother. (1987) 31:774-779. Early work describing the effect of quinolones on eukaryotic cells.
  • FORSGREN A, SCHLOSSMAN SF, TEDDER TF: 4-Quinolone •drugs affect cell cycle progression and function ofhuman lymphocytes in vitro. Antimicrob. Agents Chemother. (1987) 31:768-773. Early work describing the effects of quinolones on eukaryotic cells.
  • FORSGREN A, BREDBERG A, RIESBECK K: Effects of ciprofloxacin on human lymphocytes - laboratory stud-ies. Scand J. Infect. Dis, (1989) 60:39–45.
  • RIESBECK K, SIGVARDSSON M, LEANDERSON T, FORS-GREN A: Superinduction of cytokine gene transcription by ciprofloxacin. J. Immunol. (1994) 153:343–351.
  • KNOLLE R .1, BROM J, SCHONFIELD W, KONIG W: Influenceof ciprofloxacin on leukotriene generation from vari-ous cells in vitro. J. Antimicrob. Chemother. (1989) 25 :605–612.
  • FORSGREN A, BERGH A-K, BRANDT M, HANSSON G: Quinolones affect thymidine incorporation into the DNA of human lymphocytes. Antimicrob. Agents Chemother. (1986) 29:506–508.
  • ROCHE Y, GOUGEROT-POCIDALO M-A, FAY M, ETIENNE D, FOREST N, POCIDALO J-J: Comparative effects of quinolones on human mononuclear leucocyte func-tions. J Antimicrob. Chemother. (1987) 19:781–790.
  • ROCHE Y, FAY M, GOUGEROT-POCIDALO M-A: Inter-leukin-1 production by antibiotic-treated human monocytes. J. Antimicrob. Chemother. (1988) 21:597–607.
  • BAILLY S, FAY M, ROCHE Y, GOUGEROT-POCIDALO M-A:Effects of quinolones on tumor necrosis factor produc-tion by human monocytes. Intl. Immunopharmac. (1990) 12:31–36.
  • DE SIMONE C, BALDINELLI L, FERRAZZI M, DE SANTIS S,PUGNALONI L, SORICE F: Influence of ofloxacin, nor-floxacin, nalidixic acid, pyromidic acid and pipemidic acid on human i-interferon production and blastogene-sis. J. Antimicrob. Chemother. (1986) 17:811–814.
  • PESSINA A, NERI MG, MUSCHIATO A, MINE° E, COCUZZAG: Effect of fhtoroquinolones on the in vitro prolifera-tion of myeloid precursor cells. J. Antimicrob. Chemother. (1989) 24:203–208.
  • CUFFINI AM, CARLONE NA, XERRI L, PIZZOGLIO ME: Synergy of ceftazidime and human macrophages on phagocytosis and killing of Staphylococcus aureus and Pseudomonas aeruginosa .J. Antimicrob. Chemother. (1987) 20:261–271.
  • LABRO MT: Cefodizhne as a biological response modi- fler: a review of its in vivo, ex vivo and in vitro hrunu-nomodulatory properties. J. Antimicrob. Chemother. (1990) 26(Suppl. C):37-47. Good review of a model antibiotic for study of it's immunomodula-tory activity.
  • LABRO MT, EL BENNA J: Comparison of cefodizime withvarious cephalosporins for their indirect effect on the human neutrophil oxidative burst in vitro. J. Antimi-crob. Chemother. (1990) 26(Suppl. C):49–57.
  • AKAHANE K, FURUHAMA K. KATO M, UNE T, ONODERA •T: Influences of cephem antibiotics on the immuneresponse in mice. Chemotherapy (1990) 36:300-307. In vivo immune modulatory responses of cephems.
  • KEICHO N, KUDOH 5, YOTSUMOTO H, AKAGAWA KS: Antilymphocytic activity of erythromycin distinct from that of FK506 or cyclosporin A. J. Antibiot. (1993) 46:1406–1413.
  • NIELSEN H: Antibiotics and human monocyte function.IL Fhagocytosis and oxidative metabolism. APMIS (1989) 97:447–451.
  • NIELSEN H: Antibiotics and human monocyte function. L Chemotaxis. Acta pat hologica, Microbiologica, et Iminu-nologica Scandinavica - Section B. Microbiology (1987) 95:293–296.
  • CARLONE NA, CUFFINI AM, FERRERO M, TULLIO V, AVETTA G: Cellular uptake and intracellular bactericidal activity of teicoplanin in human macrophages. J. An-timicrob. Chemother. (1989) 23:849–859.
  • INGHAM E, TURNBULL L, KEARNEY JN: The effects ofminocycline and tetracycline on the mitotic response of human peripheral blood lymphocytes.]. Antimicrob. Chemother. (1991) 27:607–617.
  • GOLLAPUDI SVS, VAYUVEGULA B, GUPTA 5, FOK M, THADEPALLI H: Aryl-fluoroquinolone derivatives A-56619 (Difloxacin) and A-56620 inhibit mitogen-in-duced human mononuclear cell proliferation. Antimicrob. Agents Chemother. (1986) 30:390–394.
  • CUFFINI AM, TULLIO V, FAZARI S, ALLOCCO A, CARLONENA: Pefloxacht and immunity: cellular uptake, poten-tiation of macrophage phagocytosis and intracellular bioactivity for Klebsiella pneumoniae. Int. J. Tiss. React. (1992) X1V:131–139.
  • RODRIGUEZ AB, BARRIGA C, DE LA FUENTE M: Stimula-tion of phagocytic processes and antibody-dependent cellular cytotoxicity of human neutrophils by cefmeta-sole. Microbiol. and Immunol. (1991) 35:545–556.
  • RODRIGUES AB, BARRIGA C, DE LA FUENTE M: In vitroeffect of cefoxitin on phagocytic function and antibody-dependent cellular cytotoxicity in human neutrophils. Comparative Immunology, Microbiol. Infect. Dis. (1993) 16:39–50.
  • NAESS A, SOLBERG CO: Effects of two macrolide antibi-otics on human leukocyte membrane receptors and functions. APMIS (1988) 96:503–508.
  • MORIKAWA K, OSEKO F, MORIKAWA S, SAWADA M: Immunosuppressive activity of fosfomycin on human T-lymphocyte function in vitro. Antimicrob. Agents Chemother. (1993) 37:2684–2687.
  • MORIKAWA K, OSEKO F, MORIKAWA S: Immunomodu-latory effect of fosfomycin on human B-lymphocyte function. Antimicrob. Agents Chemother. (1993) 37:270–275.
  • GABLER WL, CREAMER FIR: Suppression of human neu-trophil functions by tetracycline.]. Periodont. Res. (1991) 26:52–58.
  • AGEN C, DANESI R, BLANDIZZI C, COSTA M, STACCHINIB, FAVINI P, DEL TACCA M: Macrolide antibiotics as inflammatory agents: Roxithromycin in an unexpected role. Agents Actions (1993) 38:85–90.
  • PASQUI AL, DI RENZO M, BRUNT F, FANETTI G, CANIPOC- CIA G, AUTERI A: Imipenem and immune response: in vitro and in vivo studies. Drugs Exptl. Clin. Res. (1995) XXI:17–22.
  • VAN DER AUWERA P, HUSSON M, FRUHLING J: Influence of various antibiotics on phagoeytosis of Staphylococ-cus aureus by human polymorphonuclear leucocytes. Antimicrob. Chemother. (1987) 20:399–404.
  • GLADUE RP, BRIGHT GM, ISAACSON RE, NEWBORG MF: In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytotic cells: possible mechanism of delivery and release at site of infection. Antimicrob. Agents Chemother. (1989) 33:277-282. Good research plan to explain the biological activity of this first-of-a-kind agent.
  • SCAGLIONE F, FERRARA F, DUGNANI S, DEMARTINI G, TRISCARI F, FRASCIIINI F: Inununostitnulation by clarithromycin in healthy volunteers in chronic bron-chitis patients. J. Chemother. (1993) 5:228–232.
  • KAUFMANN SHE, FLESCH IEA: Cytokines in antibacterial •resistance: Possible applications for inununomodula-tion. Lung (1990) SuppL:1025-1032. Excellent review of cytokine involvement in antibacterial therapy.
  • CALLARD RE, GEARING AIH: The Cvtokine Handbook (2nd Edition). Academic Press, NY (1994).
  • Fundamental Immunology. Paul WE (Ed.). Raven Press, NY (1993).
  • Advanced Immunoassays in Rheumatology. Teodorescu M, Froelich CJ (Eds.). CRC Press, Ann Arbor, MI (1994).
  • RITT RE: Antibiotics as biological response modifiers.]. ga,Antimicrob. Chemother. (1990) 26(Suppl. C):31-36.Excellent review of antibacterials' alternate activities.
  • ANONYMOUS: SPR-901. Drugs of the Future (1994) 19:33–34.
  • ANONYMOUS: FK-565. Drugs of the Future (1994) 19:243–247.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.